Showing results (1-10 of 167) with videos related to
Sort By:
Pageof 17
American Journal of Hypertension|April 4, 2013
Renin-angiotensin system blockers may create more risk than reward for sodium-depleted cardiovascular patients with high plasma renin levelsJean E Sealey, Michael H Alderman, Curt D Furberg, et al.Current Controlled Trials in Cardiovascular Medicine|January 25, 2002
The usefulness of information on HDL-cholesterol: potential pitfalls of conventional assumptionsCurt D FurbergCurrent Controlled Trials in Cardiovascular Medicine|January 25, 2002
A new era in hypertension research: discussing the findings of ALLHATCurt D FurbergJAMA|May 22, 2003
Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysisBruce M Psaty, Thomas Lumley, Curt D Furberg, et al.Current Controlled Trials in Cardiovascular Medicine|January 25, 2002
Withdrawal of cerivastatin from the world marketCurt D Furberg, Bertram PittAmerican Journal of Hypertension|October 10, 2002
Hypertension guidelines: criteria that might make them more clinically usefulMichael H Alderman, Curt D Furberg, John B Kostis, et al.American Journal of Hypertension|November 10, 2004
Beyond hypertension toward guidelines for cardiovascular risk reductionMassimo Volpe, Michael H Alderman, Curt D Furberg, et al.Drug Safety|November 20, 2016
The Harms of Antipsychotic Drugs: Evidence from Key StudiesThomas J Moore, Curt D FurbergDrug Safety|May 31, 2015
Electronic Health Data for Postmarket Surveillance: A Vision Not RealizedThomas J Moore, Curt D FurbergPageof 17